Search research articles
Contact Us
Filters
Showing results (211-220 of 760) with videos related to
Page
of 76
Sort By:
Journal of Thrombosis and Thrombolysis
|
December 26, 2013
Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies
Dominick J Angiolillo, Catherine Datto, Shane Raines, et al.
Progress in Cardiovascular Diseases
|
January 2, 2018
Evolution of Coronary Stent Technology and Implications for Duration of Dual Antiplatelet Therapy
Jae Youn Moon, Francesco Franchi, Fabiana Rollini, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
June 2, 2017
Role for Thrombin Receptor Antagonism With Vorapaxar in Secondary Prevention of Atherothrombotic Events: From Bench to Bedside
Jae Youn Moon, Francesco Franchi, Fabiana Rollini, et al.
Thrombosis and Haemostasis
|
June 29, 2020
Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the Evidence
Jeffrey Ian Weitz, Dominick J Angiolillo, Tobias Geisler, et al.
European Heart Journal
|
September 21, 2022
The search for optimal antithrombotic therapy in transcatheter aortic valve implantation: facts and uncertainties
Jurrien Ten Berg, Bianca Rocca, Dominick J Angiolillo, et al.
Therapeutic Advances in Cardiovascular Disease
|
July 3, 2013
Update on platelet glycoprotein IIb/IIIa inhibitors: recommendations for clinical practice
Ana Muñiz-Lozano, Fabiana Rollini, Francesco Franchi, et al.
Journal of the American College of Cardiology
|
September 5, 2020
Reply: P2Y<sub>12</sub> Inhibitor-Based Monotherapy: Optimal Duration and Ideal Agent
Dominick J Angiolillo, Usman Baber, George D Dangas, et al.
Expert Review of Hematology
|
November 2, 2017
The quest for safer antithrombotic treatment regimens in patients with coronary artery disease: new strategies and paradigm shifts
Jae Youn Moon, Francesco Franchi, Fabiana Rollini, et al.
Journal of Thrombosis and Thrombolysis
|
May 25, 2025
Antiplatelet therapy following conservatively managed spontaneous coronary artery dissection
Madeline K Mahowald, Luis Ortega-Paz, Claudio Laudani, et al.
British Journal of Clinical Pharmacology
|
September 13, 2011
Antiplatelet therapy: thrombin receptor antagonists
Antonio Tello-Montoliu, Salvatore D Tomasello, Masafumi Ueno, et al.
Page
of 76
Search research articles
Search
Showing results (211-220 of 760) with videos related to
Sort By:
Page
of 76
Journal of Thrombosis and Thrombolysis
|
December 26, 2013
Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies
Dominick J Angiolillo, Catherine Datto, Shane Raines, et al.
Progress in Cardiovascular Diseases
|
January 2, 2018
Evolution of Coronary Stent Technology and Implications for Duration of Dual Antiplatelet Therapy
Jae Youn Moon, Francesco Franchi, Fabiana Rollini, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
June 2, 2017
Role for Thrombin Receptor Antagonism With Vorapaxar in Secondary Prevention of Atherothrombotic Events: From Bench to Bedside
Jae Youn Moon, Francesco Franchi, Fabiana Rollini, et al.
Thrombosis and Haemostasis
|
June 29, 2020
Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the Evidence
Jeffrey Ian Weitz, Dominick J Angiolillo, Tobias Geisler, et al.
European Heart Journal
|
September 21, 2022
The search for optimal antithrombotic therapy in transcatheter aortic valve implantation: facts and uncertainties
Jurrien Ten Berg, Bianca Rocca, Dominick J Angiolillo, et al.
Therapeutic Advances in Cardiovascular Disease
|
July 3, 2013
Update on platelet glycoprotein IIb/IIIa inhibitors: recommendations for clinical practice
Ana Muñiz-Lozano, Fabiana Rollini, Francesco Franchi, et al.
Journal of the American College of Cardiology
|
September 5, 2020
Reply: P2Y<sub>12</sub> Inhibitor-Based Monotherapy: Optimal Duration and Ideal Agent
Dominick J Angiolillo, Usman Baber, George D Dangas, et al.
Expert Review of Hematology
|
November 2, 2017
The quest for safer antithrombotic treatment regimens in patients with coronary artery disease: new strategies and paradigm shifts
Jae Youn Moon, Francesco Franchi, Fabiana Rollini, et al.
Journal of Thrombosis and Thrombolysis
|
May 25, 2025
Antiplatelet therapy following conservatively managed spontaneous coronary artery dissection
Madeline K Mahowald, Luis Ortega-Paz, Claudio Laudani, et al.
British Journal of Clinical Pharmacology
|
September 13, 2011
Antiplatelet therapy: thrombin receptor antagonists
Antonio Tello-Montoliu, Salvatore D Tomasello, Masafumi Ueno, et al.
Page
of 76